PROF News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

PR

Mkt Cap

$219.6M

Volume

112.69K

Next Earnings

November 12th

Chart Financials Earnings News About Insider Filings

Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect?Profound Medical (PROF) closed at $7.01 with a mean analyst price target of $11.13, suggesting 58.8% upside potential. The stock has gained 23.4% over the past four weeks. Analysts have revised earnings estimates higher over the last 30 days, and PROF holds a Zacks Rank #2 (Buy) rating. However, the article cautions that price targets can be misleading and should not be the sole basis for investment decisions.Zacks Investment Research · Oct 14, 2026

Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?Profound Medical (PROF) surged 21.7% following strong preliminary Q3 2026 revenue guidance of $9.8-10 million, representing 85-89% year-over-year growth and 45-47% above analyst consensus. The company expects gross margins exceeding 70%, signaling improved commercial momentum. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the stock's momentum may not sustain without further positive estimate revisions.Zacks Investment Research · Oct 9, 2026

Why Medtech Giants Are Quietly Paying Up for AI DiagnosticsThe global AI in medical imaging market is experiencing rapid growth with a projected $2.20 billion valuation in 2026 and 34.8% CAGR through 2033. Major medtech companies including Danaher, Medtronic, DexCom, and Profound Medical are making strategic acquisitions and expanding AI-powered diagnostic platforms. Hospitals are increasingly prioritizing AI clinical solutions, with 57% ranking them as top technology priorities in 2026-2027, driving demand for validated platforms with real clinical evidence.Benzinga · Apr 29, 2026

Profound Medical Corp. Investigated by the Portnoy Law FirmThe Portnoy Law Firm has initiated an investigation into Profound Medical Corp. for possible securities fraud after the company disclosed a $472,000 revenue overstatement in Q1 2024. The error affected financial statements across multiple quarters, prompting a restatement and causing the stock to fall 5.9% to $6.86 per share on March 7, 2025. Investors are being encouraged to join a potential class action lawsuit.GlobeNewswire Inc. · Apr 9, 2026

Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30thProfound Medical Corp. successfully closed a $36 million registered direct offering of 5.14 million common shares at $7.00 per share. The company plans to use net proceeds for sales and marketing expansion, working capital, R&D, and strategic transactions. An additional $4 million private placement with Canadian purchasers is expected to close by December 30, 2025.GlobeNewswire Inc. · Dec 23, 2025

Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data PresentationDr. Pejman Ghanouni from Stanford Medicine received a Cum Laude award at RSNA 2025 for presenting results from the CAPTAIN trial, comparing MRI-guided transurethral ultrasound ablation (TULSA) with robotic radical prostatectomy for prostate cancer treatment.GlobeNewswire Inc. · Dec 4, 2025

Profound Named to Redpoint Ventures’ Inaugural AI64 List of the Most Promising AI CompaniesAI platform Profound has been recognized by Redpoint Ventures in their inaugural AI64 list, highlighting the company's innovative approach to AI-powered brand visibility and marketing optimization.GlobeNewswire Inc. · Oct 24, 2025

Profound Named to Redpoint Ventures’ Inaugural AI64 List of the Most Promising AI Companies Shaping the FutureProfound, an AI visibility and content optimization platform, was selected for Redpoint Ventures' AI64 list, recognizing the most promising private AI companies. The platform serves over 10,000 marketers from 1,000 organizations and helps brands optimize their presence in AI-powered search results.GlobeNewswire Inc. · Oct 24, 2025

High Intensity Focused Ultrasound (HIFU) Market to Reach $1.81 Billion by 2034, Growing at a CAGR of 10.4% | Rising Demand for Non-Invasive Therapeutic Solutions Driving Global Market ExpansionThe global HIFU market is expected to grow rapidly over the next decade, driven by the rising demand for non-invasive therapeutic solutions and advancements in imaging technology. Key growth regions include Asia-Pacific and North America.GlobeNewswire Inc. · Apr 16, 2025

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities lawsWolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential securities fraud after the company disclosed an error that overstated revenue by $472,000 in the first quarter of 2024.GlobeNewswire Inc. · Mar 27, 2025

PR

PROFProfound Medical Corp. Common Stock

PROF

Pay with—

Available Balance0.00

Your PositionYou don't own any PROF yet.

Related Tickers

Earnings